Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- europe
- investing
- technical analysis
- geopolitics
- gold
- Crypto
- AI
- Technology
- Commodities
- nvidia
- ETF
- earnings
- Forex
- china
- Real Estate
- banking
- oil
- Volatility
- magnificent-7
- energy
- apple
- Alternatives
- emerging-markets
- switzerland
- tesla
- United Kingdom
- assetmanagement
- Middle East
- amazon
- russia
- ethereum
- microsoft
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
Warren Buffett’s Financial Statement Rules of Thumb
Source: Brian Feroldi
What could be the impact on oil markets of the sudden war between Israel and Hamas (and the risks it could escalate)?
What could be the impact on oil markets of the sudden war between Israel and Hamas (and the risks it could escalate)? Some analysts see upside risk to à150 - others (e.g GS) are more mitigated. Reduced probability of Saudi-Israeli normalization and associated boost to Saudi production. The Wall Street Journal reported on Friday afternoon (before the attacks) that “Saudi Arabia has told the White House it would be willing to boost oil production early next year if crude prices are high—a move aimed at winning goodwill in Congress for a deal in which the kingdom would recognize Israel and in return get a defence pact with Washington, Saudi and U.S. officials said.” In GS view, the escalating conflict in Gaza reduces the likelihood of a near-term normalization in Saudi-Israeli relations. Source: www.zerohedge.com, WSJ, GS, Alpine Macro
BofA forecasts that ~48M US patients will have seen anti obesity medications by 2030
Source: TME, BofA
In a study of the educational backgrounds of 52 famous tech CEOs and founders, it was found that 10 out of the 52 either dropped out or were expelled like Bill Gates
By Genuine Impact
Amazon's annual R&D expenses for 2022 amounted to $73.213 billion, marking a 30.62% increase from 2021
These R&D costs accounted for 14% of its total revenue. Source: Genuine Impact
Investing with intelligence
Our latest research, commentary and market outlooks

